Cargando…

MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation

SIMPLE SUMMARY: Glioblastoma (GBM) is the most lethal brain tumor with a median survival rate of approximately 14 months. GBM patients commonly suffer from tumor recurrence, indicating that populations of chemo/radio-resistant stem cell-like tumor cells survive treatments. Here we reveal that the ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pötschke, Rebecca, Haase, Jacob, Glaß, Markus, Simmermacher, Sebastian, Misiak, Claudia, Penalva, Luiz O. F., Kühnöl, Caspar D., Hüttelmaier, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762192/ https://www.ncbi.nlm.nih.gov/pubmed/33291443 http://dx.doi.org/10.3390/cancers12123654

Ejemplares similares

MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression
por: Misiak, Danny, et al.
Publicado: (2021)

IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
por: Haase, Jacob, et al.
Publicado: (2020)

IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors
por: Müller, Simon, et al.
Publicado: (2018)

LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation
por: Feng, Jianbo, et al.
Publicado: (2021)

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway
por: Sun, Jinmin, et al.
Publicado: (2021)

Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification)
por: Braun, Juliane, et al.
Publicado: (2014)

The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer
por: Müller, Simon, et al.
Publicado: (2020)

IGF2BP1 promotes SRF-dependent transcription in cancer in a m(6)A- and miRNA-dependent manner
por: Müller, Simon, et al.
Publicado: (2019)

K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation
por: Zhao, Yi, et al.
Publicado: (2021)

Sensitivity of GBM cells to cAMP agonist-mediated apoptosis correlates with CD44 expression and agonist resistance with MAPK signaling
por: Daniel, Paul M, et al.
Publicado: (2016)

Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells
por: Reuter, Dajana, et al.
Publicado: (2015)

Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)

IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
por: Glaß, Markus, et al.
Publicado: (2021)

Post-transcriptional regulation of MRTF-A by miRNAs during myogenic differentiation of myoblasts
por: Holstein, Ingo, et al.
Publicado: (2020)

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
por: Makowska, Marianna, et al.
Publicado: (2023)

The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
Publicado: (1992)

IGF2BP1—An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation
por: Glaß, Markus, et al.
Publicado: (2023)

Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice
por: Müller, Simon, et al.
Publicado: (2020)

Knockout of RNA Binding Protein MSI2 Impairs Follicle Development in the Mouse Ovary: Characterization of MSI1 and MSI2 during Folliculogenesis
por: Sutherland, Jessie M., et al.
Publicado: (2015)

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
por: Glaß, Markus, et al.
Publicado: (2020)

The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice
por: Sundar, Jesse, et al.
Publicado: (2020)

Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies
por: He, Michelle Junyi, et al.
Publicado: (2022)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

Drosophila Rbp6 Is an Orthologue of Vertebrate Msi-1 and Msi-2, but Does Not Function Redundantly with dMsi to Regulate Germline Stem Cell Behaviour
por: Siddall, Nicole A., et al.
Publicado: (2012)

The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family
por: Busch, Bianca, et al.
Publicado: (2016)

Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis
por: Du, Yong, et al.
Publicado: (2016)

miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1
por: Liu, Chang, et al.
Publicado: (2022)

Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer
por: Heregger, Ronald, et al.
Publicado: (2023)

Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features
por: Rios Velazquez, Emmanuel, et al.
Publicado: (2015)

Differentiation of Human GBM From Non-GBM Brain Tissue With Polarization Imaging Technique
por: Liu, Yi-Rong, et al.
Publicado: (2022)

The Phenotypic Radiation Resistance of CD44(+)/CD24(−or low) Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
por: Yin, Hong, et al.
Publicado: (2011)

Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
por: Garbe, Yvette, et al.
Publicado: (2011)

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells
por: Mukherjee, Sumit, et al.
Publicado: (2018)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Advances in nanotechnology for the treatment of GBM
por: Wei, Dongyan, et al.
Publicado: (2023)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

CD44 as a potential diagnostic tumor marker
por: Basakran, Nawwaf S.
Publicado: (2015)

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies
por: Segelmark, Mårten, et al.
Publicado: (2012)

Retracted: miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_okh2j54p6jao98g5lr13bu0hqj